A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.

Abstract

OBJECTIVE This study aimed at assessing the efficacy and safety of oxaliplatin plus oral capecitabine (XELOX regimen) as first-line chemotherapy in elderly patients with advanced gastric cancer (AGC). PATIENTS AND METHODS Forty-six eligible patients aged ≥70 years with previously untreated AGC received oxaliplatin 130 mg/m(2) intravenously over a 2-hour… (More)
DOI: 10.1159/000335585

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.